Both collateral vessel enlargement (arteriogenesis) and capillary growth (angiogenesis) in skeletal muscle occur in response to exercise training. Vascular endothelial growth factor (VEGF) is implicated in both processes. Thus, we examined the effect of a VEGF receptor (VEGF-R) inhibitor (ZD4190, AstraZeneca) on collateral-dependent blood flow in vivo and collateral artery size ex vivo (indicators of arteriogenesis) and capillary contacts per fiber (CCF; an index of angiogenesis) in skeletal muscle of both sedentary and exercise-trained rats 14 d following bilateral occlusion of the femoral arteries. Total daily treadmill run-time increased appreciably from ~70 to ~100 min (@ 15-20 m/min, twice/day) and produced a large (~75%, p<0.01) increase in calf muscle blood flow and a greater size of the collateral artery (wall crosssectional area). ZD4190, which previously has been shown to inhibit the activity of VEGF-R2
Introduction
The vasculature of skeletal muscle can remodel itself to enhance oxygen delivery to the active muscle. Remodeling occurs when the existing vasculature becomes insufficient to meet tissue metabolic demands, secondary to either increased muscle activity (exercise training) or vascular obstruction (peripheral arterial insufficiency). Two distinct types of vascular remodeling can occur in skeletal muscle. "Arteriogenesis" results in an increase in the number and/or size of collateral vessels delivering flow to the muscle, while "angiogenesis" results in an increase in the number of capillaries important for blood/muscle oxygen exchange (41, 50).
Arteriogenesis and angiogenesis differ on several levels. Arteriogenesis involves the enlargement of existing arteries and involves both endothelial and smooth muscle cell proliferation (40). The expanded cross-section of the collateral vasculature results in increased blood flow capacity to downstream tissue. This effect can be clearly seen in animal models of peripheral arterial insufficiency (17, 19) . Although the improvement in blood flow can relieve ischemia in the downstream tissues, ischemia is not thought to be the initiating stimulus for arteriogenesis, as the tissue in which the remodeling collateral vessels are found is not itself ischemic (17, 19) . Rather, shear stress is thought to be the major stimulus for arteriogenesis two different speeds (20 m/min and 25 m/min, 15% grade). This protocol allowed us to verify that maximal collateral-dependent blood flow was being measured. Since upstream resistance determines blood flow to collateral-dependent muscle when downstream resistance in the active muscle is minimal, the finding that blood flow is the same at both speeds indicates that maximal collateral-dependent flow has been measured.
Blood flow was measured first while the rats ran at low speed (20 m/min). After the rats had been running for one minute, microspheres bearing the first radiolabel were delivered via the aortic catheter. Meanwhile, beginning 10 s before microsphere infusion and continuing throughout microsphere administration (total time, 1 min 30 s), a reference blood sample was collected from the caudal catheter (flow rate, 0.5 mL/min). After microsphere delivery, the aortic catheter was flushed with saline over ~20 s. Careful deliberate infusion of microspheres into the ascending aorta provides a valid measure of blood flow to the distal limbs. Rats were then allowed to rest for approximately 5 min. During this period, blood pressures and heart rates returned to pre-exercise levels. The procedure was then repeated with the rats running at 25 m/min, using microspheres with the second radiolabel.
After microsphere infusion, the rats were anesthetized with sodium pentobarbital (60 mg/kg i.p.). Samples of the perforating artery were collected for measurement of collateral vessel diameter, using a 50x dissecting microscope, and for use in RT-PCR (see below).
Muscle samples were also dissected from one limb for histological analysis (see below). Rats were then killed with an overdose of sodium pentobarbital and tissues were dissected from the other hindlimb for blood flow measurement. These samples were counted in a gamma counter (Wallac Wizard 1480 Autogamma Counter, Turku, Finland), along with the reference blood samples. Muscle blood flow (mL/min/100 g) was calculated as:
Blood flow = (0.5 mL/min x CPM RBS ) / (CPM tissue x tissue weight) x 100 where RBS = the reference blood sample and CPM = counts per minute. To provide evidence that proper mixing of microspheres occurred within the circulation, the right and left kidney blood flows were compared. Blood flows to the proximal, distal, and total hindlimb were calculated by summing blood flows to individual tissues of the limb (50, 51, 53) .
Determination of collateral artery diameter and wall thickness. The perforating artery is a major collateral vessel in the medial thigh area that enlarges following femoral artery occlusion (28). A segment of the perforating artery (5 to 8 mm in length nearest its insertion into the distal femoral/popliteal artery) was collected after microsphere infusion and immediately placed in ice-cold (4 °C), calcium free, MOPS-buffered physiological saline In order to simulate conditions in vivo, the perfusion reservoirs attached to each end of the artery were gradually elevated to raise the intra-luminal pressure to >100 cmH 2 O. Maximum luminal diameter was reached when imposition of a higher intra-luminal pressure (~100 to120 cmH 2 O) resulted in no further change in vessel diameter. At this time, both maximal luminal diameter and vessel wall thickness were measured and recorded.
Histological analysis. After microsphere infusion, a section from the center of the white gastrocnemius muscle was collected, mounted on a cork with TBS tissue freezing medium (Triangle Biomedical Sciences, Durham, NC), and frozen in liquid N 2 -cooled isopentane for histological analysis. Frozen sections (10 µm) were cut using a cryostat (Leica, CM 1850). The sections were fixed in acetone and stained for alkaline phosphatase activity to identify capillaries (34), then counter-stained with metanil yellow. Images of each muscle were captured with a digital CCD camera (Spot, Diagnostic Instruments, Inc., Sterling Heights, MI) attached to a microscope (Nikon Eclipse E600, Nikon Inc., Torrance, CA). Using Adobe Photoshop software, a composite image covering the entire section was produced for each muscle. A grid was overlaid on the image and 20 non-overlapping fields were selected for analysis. An image was acquired in each field (actual image area, ~0.06 mm 2 ). The number of myocytes and the number of capillaries surrounding each myocyte were counted using Adobe Photoshop and recorded for calculation of capillary contacts per fiber.
RNA isolation. Total RNA was isolated from the collateral artery (perforating), obtained from the contralateral limb from that used for in vitro artery measurement described above, 
Results

VEGF receptor inhibition.
The VEGF receptor antagonist was well-tolerated by the animals. Of the 55 rats, one ZD4190-treated animal and one of the vehicle-treated showed histological evidence of muscle damage (inflammatory cell infiltration, focal fiber atrophy). As both animals were exercise trained, this is suggestive of over use injury. Thus, ZD4190
administration is not implicated in the muscle damage. No effects on body weight, hindlimb weight, heart rate, or blood pressure were detected (Tables 1 and 2) , and ZD4190-treated animals had normal exercise capacity. This implies that acute effects of VEGF (e.g., in acute regulation of NO) are not important in cardiovascular regulation. In sedentary rats, antagonist administration had no effect on hindlimb blood flow (Table 3) .
Exercise training. Daily running time increased rapidly over the first week of the training program, from 67±2.3 min on day 1 to 108±0.5 min on day 7 ( Figure 1 ). Thereafter, running time remained relatively constant, but running speed continued to increase.
There was no effect of ZD4190 on body weight. However, body weights of TR rats and TR+VEGF rats were significantly less (~15%, p<0.05) than those of SED rats, a typical response of male rats to exercise training (Table 1) .
Collateral blood flow: effect of training and VEGF-R antagonism. While there were
Am J Physiol H006786-2004R1 Page 8 differences in blood flows to the hindlimbs of animals among groups (cf., Table 3 ), tissues that include the proximal hindlimb are not completely collateral-dependent. Therefore, it is more appropriate to focus on the response of the calf muscles, which exhibited significant increases in the animals that were exercised daily (~70% in the TR group, and ~80% in the TR + VEGF group; cf., Figure 2 and Table 3 ). VEGF administration did not further increase collateral blood flow in combination with daily exercise. Blood flows to individual muscles that comprise the distal hindlimb were uniformly elevated by exercise training (cf., Table 4 ).
As illustrated in Figure 2 , treatment with the VEGF receptor antagonist ZD4190 completely blocked the training-induced increase in collateral blood flow. Since blood pressures were not different, the results are the same if the data are expressed as conductances. Blood flows to the total hindlimb, proximal hindlimb, distal hindlimb, and GPS group in TR+ZD4190 rats were not significantly different from that in SED rats ( Figure 2 and Table 3 ). The absence of any improvement in collateral blood flow to the calf muscles in the TR + VEGF group that was given ZD4190 attests to the effective inhibition of VEGF's actions, as VEGF independently will significantly increase calf muscle blood flow (56) . Thus, the VEGF signaling pathway appears to be of crucial importance in the training-induced increase in collateral blood flow.
Kidney and non-hindlimb muscle blood flow: effect of training and VEGF-R antagonism.
As typical when microspheres are well-mixed in aortic blood flow upon delivery, there was an excellent match in blood flow across kidneys (ratio of flows left kidney/right kidney = 1.08±0.022; n=107 measurements). There was a main treatment effect of Training to increase renal blood flows (Table 5 , p<0.025). However, this effect of training was dependent upon the absence of VEGF-R inhibition (i.e., there was a significant interaction; p<0.05). Thus, there is a correspondence between a greater renal blood flow and an improvement in collateral blood flow to the calf muscles. Training had no effect on blood flow to non-hindlimb muscle (abdominal muscle, psoas, diaphragm). Thus, the effect of training to increase blood flow was specific to the tissue at risk of ischemia following femoral occlusion.
Muscle capillarity: effect of training and VEGF-R antagonism. Training induced angiogenesis within the active muscle, as demonstrated by an increase in capillarity (22-25% increase in capillary contacts per fiber) in the white gastrocnemius (WG, Figure 3 ). This increase in capillarity with training is not due to an increase in frequency of capillaries adjoining multiple fibers (Unpublished Observations). Further, VEGF exhibited no influence on muscle capillarity. Therefore, corresponding animals that were kept sedentary, trained, or given ZD4190 were combined for clarity of illustration of VEGF-R inhibition. Treatment with ZD4190 reduced the training-induced increase in CCF. VEGF treatment did not rescue the training effect. The number of capillary contacts per fiber in ZD4190-treated rats was signifi-
cantly lower than that in TR rats, but remained significantly greater than that in SED rats (p<0.01). Thus, in contrast to its effect on blood flow, ZD4190 did not completely abolish the increase in capillarity produced by training.
Collateral vessel enlargement: effect of training and VEGF-R antagonism.
In the absence of VEGF-R inhibition, trained animals exhibited a trend (p<0.10) toward a greater luminal diameter of the collateral vessel, as compared to the SED group. ZD4190 administration eliminated this trend, as collateral vessel sizes among all three VEGF-R inhibited groups were similar to that observed in the SED group (cf., Table 6 ). Exercise training significantly increased (p<0.001) vessel wall area and this effect was eliminated with ZD4190 (cf., Table 6 ).
Thus, the absence of a change in collateral vessel size is consistent with the absence of a blood flow increase with ZD4190 administration.
Angiogenic gene expression in collateral arteries: effect of ligation, training, and VEGF-R
antagonism. There was no appreciable change in VEGF or VEGF-R2 (KDR) mRNA expression in response to any of the treatments. On the other hand, expression of mRNA for the VEGF-R1 (Flt-1) was not affected by ligation alone but was increased in the TR and TR+VEGF groups. This increase was not affected by ZD4190 treatment (Figure 4 ). There was a main treatment effect of ligation to increase the mRNA expression of PlGF, the ligand specific for VEGF-R1. This tended to be less robust in the presence of ZD4190 administration (cf., Figure   4 ). Endothelial NOS mRNA expression was increased in vessels of SED rats, relative to nonligated sedentary CONT animals ( Figure 5 ). Similar increases in eNOS mRNA were found in TR and TR+VEGF animals. ZD4190 treatment tended to further increase eNOS mRNA, although the effect was only significant in the TR+VEGF+ZD4190 group.
No effect of ligation, training or VEGF-R antagonist treatment was found for VEGF-B, angiopoietin-1, angiopoietin-2, the angiopoietin receptor Tie-2 or MCP-1 mRNA expression, relative to CONT (data not shown).
Discussion
Our findings demonstrate the importance of VEGF receptor signaling in vascular adaptations to exercise training and reveal intriguing potential differences in the signaling pathways regulating collateral vessel enlargement (arteriogenesis) and enhanced muscle capillarity (angiogenesis). resting quiescent muscle (24). As a result, there is no increase in capillarity (22), typical of ischemic muscle. Thus, there is no opportunity for VEGF inhibition to alter muscle capillarity in our short-term study when the animals are kept sedentary. This is in contrast to the more long-term absence of VEGF expression which leads to an appreciable diminution of muscle capillaries, apoptosis of myocytes and endothelial cells, and the resulting increased potential for focal ischemia (37).
Training-induced arteriogenesis requires normal VEGF receptor function.
We induced peripheral arterial insufficiency in rats by bilateral ligation of the femoral arteries, which removes ~85-90% of the flow reserve to the distal hindlimb (55) . elimination of the increase in collateral blood flow, with VEGF receptor tyrosine kinase inhibition, was coincident with elimination of the enlargement of the isolated collateral vessel (cf., Table 6 ). This absence of vessel remodeling implies that the endothelial and vascular smooth muscle proliferation, typically observed with arteriogenesis (19, 33) , and other coordinated events necessary for arteriogenesis to proceed (e.g., extracellular matrix remodeling (38, 42)), did not occur.
How the VEGF receptor tyrosine kinase signaling is instrumental in the exercise-induced enlargement of collateral vessels has yet to be explored. The two receptors, VEGF-R1 (Flt-1)
and VEGF-R2 (KDR), exhibit different specificities for the VEGF-family of growth factors.
Further, each receptor can exhibit distinct effects. Most attention has been focused on VEGF-R2 receptor, since it is generally thought to be the major mediator of the mitogenic and angiogenic effects of VEGF (11) . However, recent evidence suggests that the role of VEGF-R1
in angiogenesis and vascular remodeling may be more significant than previously thought. is implied by the exaggerated upregulation of eNOS in the exercised groups that received ZD4190. Recall that collateral vessel enlargement was not observed in animals subjected to VEGF receptor kinase inhibition (Table 6 ). In the absence of an enlarged vessel caliber, any increase in blood flow through these vessels above rest should prompt a greater shear stress.
Thus, absence of collateral vessel enlargement should sustain a greater shear stress any time the animals were exercised, and hence the exaggerated upregulation in eNOS mRNA in the ZD4190-treated animals. The benefit of an improved capacity for NO production would not be realized, however, since VEGF receptor kinase inhibition (cf., Table 6 ) would preempt the NOdependent VEGF-induced arteriogenesis (56) . Thus, alterations in mRNA expression in the collateral vessels implicates eNOS, VEGF-R1, and PlGF in collateral vessel enlargement;
however, their specific roles remain to be evaluated experimentally.
VEGF receptor antagonism partially blocks training-induced angiogenesis in active muscle.
VEGF has been identified as a key mediator of physiological angiogenesis in a wide variety of circumstances (11), including exercise training (2) . VEGF mRNA is upregulated with muscle contractions and immediately following exercise (4, 14, 15) . The magnitude of VEGF upregulation with acute exercise lessens over the days of training (31), roughly in parallel with the increase in muscle capillarity induced by ischemic exercise (21); however, VEGF protein and the number of VEGF-positive capillaries remains elevated in the ischemic muscle (26).
Further, the increase in microvascular density observed after 3 days (23%) of treadmill walking or 7 days (30%) of muscle contractions was eliminated when VEGF upregulation was inhibited or when VEGF was scavenged with an antibody (1, 2) . Thus, the actions of VEGF appear to be vital to the angiogenic adaptation in active muscle by exercise. The present results extend these observations to demonstrate the importance of VEGF-R1 and/or -R2 tyrosine kinase activity. The loss of the increased capillarity in response to training was therefore expected. However, our findings suggest that the training-induced adaptation of increased muscle capillarity is more complicated than simply a function of VEGF availability and receptor signaling. While ZD4190 significantly reduced the magnitude of the angiogenic response, it did not eliminate the increase in capillarity. Thus, a careful evaluation of the data set and experiment is warranted. via integrin-receptor interaction that is independent of ligand activation (43), this also would be inhibited by ZD4190, since it is the tyrosine kinase activity that is inhibited by ZD4190 and not VEGF binding to the receptor. Thus, it is reasonable to conclude that any reduction in capillarity as observed in the TR+ZD41490 group (cf., Figure 3 ) is assignable first to inhibition of VEGF-R2 tyrosine kinase activity.
In a manner consistent with the above interpretation, it is possible that the VEGF-R1 tyrosine kinase activity remained relatively active. The IC 50 for inhibition by ZD4190 is less effective and the affinity of VEGF-R1 for VEGF much higher (an apparent Kd of 0.6 nM (30)).
Thus, the significant increase in muscle capillarity that remained with ZD4190 treatment (cf., by some VEGF receptor-independent angiogenic signal that has yet to be described. This is in contrast to the complete elimination of the training-induced increase in collateral blood flow (arteriogenesis) with VEGF receptor kinase inhibition. 
